Genetic diagnostic methods are becoming more widely applied, both for inherited diseases (such as neurofibromatosis type 1) and for tumours (eg, BRAF testing in cutaneous and conjunctival melanoma). This evidence concerns the gene BRAF and neurofibromatosis type 1.